Olaf-Oliver Wolz
4PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 18, 2024
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.Brandon J Essink, Craig Shapiro, Marie Grace Dawn Isidro
|Apr 27, 2024
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity.Olaf-Oliver Wolz, Dominik Vahrenhorst, Gianluca Quintini
|Apr 23, 2022
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant.Olaf-Oliver Wolz, Sarah-Katharina Kays, Helga Junker
|Sep 23, 2021
BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity.Zsófia Agnes Bittner, Xiao Liu, Maria Mateo Tortola
Pageof 1
Frequent Collaborators
3 joint publications
Philipp Mann
1 joint publications
Zsófia Agnes Bittner
1 joint publications
Xiao Liu
1 joint publications
Maria Mateo Tortola
1 joint publications
Ana Tapia-Abellán
1 joint publications
Sangeetha Shankar
1 joint publications
Liudmila Andreeva
1 joint publications
Matthew Mangan
1 joint publications
Marianne Spalinger
1 joint publications
Hubert Kalbacher
